GbBIS Introduces the Most Accurate ZIP+4 Demographic Data

Businesses benefit from advanced technology that accurately projects demographic data into ZIP+4 geographies.

2012-07-24

IRVINE, CA, July 24, 2012 (Press-News.org) GbBIS, a leading resource for geography-based business information solutions, announced today the release of ZIP+4 demographic data. Using advanced proprietary technology, GbBIS most accurately projects demographic data into ZIP+4 geographies created to the CASS Certification standards. Annual, quarterly, and monthly updates are available. ZIP+4 demographics help businesses target neighborhoods for direct mail, as well as organize mailings to maximize postal discounts.

GbBIS's proprietary process projects demographic data from Nielsen, AGS, and the US Census Bureau, into ZIP+4 postal geographies. GbBIS technology applies USPS postal delivery data and street databases to produce the most accurate projections. Businesses receive demographic data, Census information, and product consumption statistics, giving them an efficient way to organize and target their direct mail. ZIP+4 demographic data gives businesses a detailed way to evaluate their target market by neighborhood and make business decisions based on variations between neighborhoods.

Dan Olasin, President and CEO of GbBIS states that "[O]ur proprietary process ensures that demographic data is accurately projected into ZIP+4 areas. Monthly updates and CASS Certification compatibility deliver information businesses can trust."

ZIP+4 demographic data is available as data on maps, databases, reports, and web applications. Businesses interested in accurate data to increase the efficiency and cost effectiveness of their direct mail should contact Theresa Bordas, National Client Services Manager, at 1-877-447-6277 or theresa.bordas@gbbis.com.

About GbBIS
GbBIS, a division of Intelligent Direct Inc., is a leading provider of geographic-based business information solutions. GbBIS has 20 years of experience assisting businesses by offering a variety of mapping software, mapping data, innovative project consulting, and customized GIS data. During that time, GbBIS has delivered over 100,000 projects to clients from the US, Canada, and Worldwide. Today, GbBIS maintains a relationship with nearly 100% of the Fortune 500 Companies. For additional information, visit www.gbbis.com and call 1-877-447-MAPS (6277).

EDITORIAL CONTACT:
Theresa Bordas
National Client Services Manager
GbBIS, a division of Intelligent Direct Inc.
1-877-447-6277
theresa.bordas@gbbis.com

ELSE PRESS RELEASES FROM THIS DATE:

Startuppers.org Gives Any Startup a Chance to Tell The World its Story

2012-07-24

We are living in the world of startups, where hundreds of new companies are formed every day. They are working on their startups day & night, and attending events like Startup Weekend. But just few startups of them get it to the finish line. Just few of them get some media coverage and have a chance to meet with angel investors. With Startuppers.org coming on stage, all of that will change. Startuppers.org is a new way of startup communication. It is a hybrid between social network and blogger. It is like joining Facebook, Techcrunch and Mashable all together, taking ...

Time to Sign Sports Announces the Commitments of Pitchers Paul Balestrieri (2013) to Cornell and Christopher Monaco (2014) to Virginia Tech and Shortstop Matt McCann (2013) to Fairleigh Dickinson

2012-07-24

Time to Sign Sports, through its advisory services, assists high school baseball players navigate through the college baseball recruiting process. The successes they have enjoyed are incredible. Those successes continued this past week. "Paul Balestrieri (2013 RHP) is one of those special young men," says Gary Cohn, co-founder of Time to Sign Sports. He continues, "Getting drafted in the early rounds or eventually becoming the President of the United States would come as no surprise to anyone that knows Paul." Cornell, in a very competitive recruiting ...

My7's E Cigarettes Introduce Grape Cartomizers to Their Lineup

2012-07-24

From zero nicotine to high, My7's grape flavor has been a huge hit among users of the popular brand. Now the company releases its pre-filled cartomizers for the public. The company has been aggressively adding a plethora of flavors to meet the demand of smokers across the country and is expected to explode sales of the already popular brand. Flavors offer smokers more options when it comes to the new smoking alternative that is taking the nation and world by storm. While there are some naysayers, most agree that flavors add a new and refreshing change for smokers ...

deVere Group Announces Strong Half-Year Results

2012-07-24

After announcing massive expansion plans across all 5 continents last year, with the number of offices now totalling 69, of which 13 branches were opened in this year alone, deVere CEO Nigel Green is delighted to announce that the efforts have paid off with very successful results. As of June 2012, year-to-date figures have increased by 15% from 2011. Notably, its new currency service deVere Foreign Exchange is growing rapidly, by a staggering 434% since last year. The deVere Fund Platform, the industry-leading interactive hub which holds a 5,000+ fund selection, is ...

For gay couples, condom decision-making and condom use varies by race

2012-07-23

Black gay couples tend to practice safe sex but don't talk about it, while white gay couples discuss safety but are less likely to use condoms, according to new findings presented at the 19th International AIDS Conference. Gay men, particularly white and black men, account for the majority of new HIV cases in the United States. One source of HIV infection could be men's primary relationship partners. To explore this aspect of risk, San Francisco State University researchers studied how black, white and interracial male couples make decisions about using condoms. In ...

Clinical study in rural Uganda shows high demand for antiretroviral drugs

2012-07-23

An ongoing clinical study in rural Uganda, begun in 2011, suggests that many people infected with HIV/AIDS would take antiretroviral drugs if they were available to them—even before they developed symptoms from the disease. Led by doctors at the University of California, San Francisco (UCSF), the San Francisco General Hospital and Trauma Center (SFGH) and Makerere University School of Medicine in Kampala, Uganda, the study is the first to address such attitudes among African patients who are in the early stages of the disease and not yet sick. Historically, treatment ...

Increased cardiovascular risk in HIV-infected patients may relate to arterial inflammation

2012-07-23

The elevated risk of cardiovascular disease seen in patients infected with HIV appears to be associated with increased inflammation within the arteries, according to a study that will appear in a special issue of JAMA published in conjunction with the International AIDS Conference. The report from Massachusetts General Hospital (MGH) found that levels of inflammation within the aortas of HIV-infected individuals with neither known cardiovascular disease nor elevated traditional risk factors were comparable to those of patients with established cardiovascular disease. "Several ...

HIV suppression not as good as previously thought, largest study of viral-load blood tests show

2012-07-23

Tens of thousands of Americans taking potent antiretroviral therapies, or ART, to keep their HIV disease in check may not have as much control over the viral infection as previous estimates have suggested, according to results of a study by AIDS experts at Johns Hopkins and the University of Pennsylvania. In what is believed to be the largest and longest review of viral load test results in people with HIV disease ever performed in the United States, researchers found that the number of people sustaining viral suppression – consistently, at 400 or less viral copies ...

HIV-infected women do not appear to be at increased risk of cervical cancer

2012-07-23

WASHINGTON, D.C. – HIV-infected and uninfected women with normal cervical cytology (Pap test) and a negative test result for oncogenic (tumor inducing) human papillomavirus DNA at study enrollment had a similar risk of cervical precancer and cancer after 5 years of follow-up, according to a study in the July 25 issue of JAMA, a theme issue on HIV/AIDS. Howard D. Strickler, M.D., M.P.H., of the Albert Einstein College of Medicine of Yeshiva University, New York, presented the findings of the study at a JAMA media briefing at the International AIDS Conference. "U.S. ...

Working toward an AIDS-free generation

2012-07-23

WASHINGTON, D.C. – Ending the global HIV/AIDS pandemic may be possible by implementing a multifaceted global effort that expands testing, treatment, and prevention programs, as well as meets the scientific challenges of developing an HIV vaccine and possibly a cure, according to a Viewpoint in the July 25 issue of JAMA, a theme issue on HIV/AIDS. Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Md., presented the article at a JAMA media briefing at the International AIDS Conference. Dr. Fauci and co-author ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

GbBIS Introduces the Most Accurate ZIP+4 Demographic Data

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: